Our collaborative investor engagement on Antibiotics was supported by more than 70 institutional investors, representing $5.5 trillion in AUM. To protect public health and…
Antimicrobial resistance (AMR): how animal pharmaceuticals are driving the next global public health crisis.
Today, 70% of global antimicrobials are fed to intensively farmed livestock, accelerating the risk of widespread antimicrobial resistance. Our latest research, Feeding Resistance, explores the role of animal pharmaceuticals in driving AMR, and how investors can engage the sector to drive better stewardship.
On 21 July 2021, we held a special webinar to mark the launch of the report and share the key findings from our research. We were joined by a panel of AMR experts, including:
• Dr Emma Berntman, Engagement Lead, EOS at Federated Hermes
• Professor Will Gaze, University of Exeter Medical School
• David Tsoupros, Senior Research Analyst, AllianceBernstein
• Susannah Savage, Lead AMR Reporter, The Bureau of Investigative Journalism
Members & Non-Members
Read the Executive Summary to find out key information regarding the contribution of animal agriculture to AMR and the current practices of the ten largest publicly listed animal pharma companies.
Full Report (Members)
Access the full report to learn about the contribution of animal agriculture to AMR. The analysis examines current practices of the ten largest publicly listed animal pharma companies and outlines key actions that the sector must take to mitigate the risks of AMR.
Full Report (Non-Members)
Delve into our latest report, Feeding Resistance, which provides a unique sectoral analysis of the animal pharma industry and explores the widespread impact of antibiotic use in the livestock industry. The report is now available to non-members for a one-off payment.
Animal Pharma Resources
The FAIRR Initiative publishes a wide range of research to help investors understand and manage the risks and opportunities linked to intensive livestock production.
A coalition between the Access to Medicine Foundation, the FAIRR Initiative, the Principles for Responsible Investment and the UK Government Department of Health and…
The cultured meat industry is predicted to be worth $572 million by 2027, representing a compounded annual growth rate of 15%. This expansion is…
As part of World Antibiotics Awareness Week, the FAIRR Initiative is pleased to take part in this insightful panel discussion on…
Antimicrobial resistance (AMR) is now globally acknowledged as a fundamental threat to public health and the global economy. The overuse and misuse of antibiotics…
Outlines investment risks linked to farm antibiotic misuse, and how investors can drive improvements in the food industry.…
2017 update on how fast food giants are reducing use of medically important antibiotics following FAIRR's engagement.…